Background and purpose: To obtain adequate spatial dose distribution f
or endobronchial brachytherapy, we applied reference dose points accor
ding to the bronchial diameter. For this purpose, we devised a new app
licator of which the source transfer tube is contained in the center o
f the lumen for high dose rate (HDR) brachytherapy. Materials and meth
ods: Thirty-nine patients with endobronchial cancer underwent endobron
chial brachytherapy using an HDR afterloading machine with an Ir-192 s
ource. In the nine patients treated with curative intent, treatment co
nsisted of external beam radiotherapy with 40-60 Gy for 4-6 weeks and
endobronchial brachytherapy with three fractions of 6 Gy. The 30 patie
nts treated with palliative intent received one fraction of 10 Gy with
or without external beam irradiation. The reference dose points were
prescribed according to bronchial diameter, which was measured by the
applicator's radiopaque wing expansion reflecting the bronchial calibe
r. Results: The new applicator could be placed at the intended site in
37 lesions. Of 12 lesions which were treated with curative intent, ei
ght (67%) disappeared after brachytherapy. The overall survival at 3 y
ears of all patients and of the patients treated with curative intent
was 22 and 64%, respectively. Conclusions: The source should be positi
oned in the center of the lumen; this technique is helpful in reducing
side-effects caused by inhomogeneous dose distribution of endobronchi
al brachytherapy. (C) 1997 Elsevier Science Ireland Ltd.